Tian Zi-Yue, Jiang Bing, Jin Meng, Yu Xiao-Kun, Chen Qi-Lin, Wang Jia-Hui
Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Department of Integrated Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
Front Aging Neurosci. 2025 Apr 8;17:1542607. doi: 10.3389/fnagi.2025.1542607. eCollection 2025.
Alzheimer's disease (AD) is the fastest-growing neurodegenerative disorder globally, with patient numbers expected to rise to 130 million by 2050. Insomnia, a prevalent comorbidity, exhibits a bidirectional relationship with AD: insomnia accelerates AD pathology, while AD worsens sleep disorders. This relationship has emerged as a key area of research. Current mechanisms involve oxidative stress, inflammatory responses, and glymphatic system dysfunction, yet a comprehensive review of these processes remains absent.
To conduct a visual analysis of the relationship between Alzheimer's disease and insomnia using CiteSpace.
Literature on "insomnia" and "Alzheimer's disease" published between January 1, 2000, and October 31, 2024, was retrieved from the Web of Science Core Collection. CiteSpace and VOSviewer software were used to analyze institutions, authors, and keywords.
A total of 1,907 articles were analyzed, revealing a consistent upward trend in publication volume. The United States and the Mayo Clinic were identified as leading contributors, producing 704 and 57 publications, respectively. Boeve Bradley F the most prolific author contributed 30 publications. Collaboration was actively observed among countries, institutions, and authors. High-frequency keywords identified were "Parkinson's disease," "cognitive impairment," and "sleep behavior disorder." Emerging research areas are likely to focus on "sleep quality" and the "glymphatic system."
This study is the first to apply bibliometric analysis to identify three key trends in AD and insomnia research: the dominance of the United States and Mayo Clinic, strong international collaboration, and a focus on critical areas such as cognitive impairment, the glymphatic system, and sleep interventions. Insomnia may accelerate AD progression via multiple pathways, indicating that enhancing sleep quality could provide new strategies for early intervention. Future research should prioritize advancing the clinical translation of sleep interventions and investigating the mechanisms of the glymphatic system.
阿尔茨海默病(AD)是全球增长最快的神经退行性疾病,预计到2050年患者数量将增至1.3亿。失眠是一种常见的共病,与AD呈现双向关系:失眠加速AD病理进程,而AD则使睡眠障碍恶化。这种关系已成为一个关键研究领域。目前的机制涉及氧化应激、炎症反应和脑淋巴系统功能障碍,但对这些过程仍缺乏全面综述。
使用CiteSpace对阿尔茨海默病与失眠之间的关系进行可视化分析。
从Web of Science核心合集中检索2000年1月1日至2024年10月31日发表的关于“失眠”和“阿尔茨海默病”的文献。使用CiteSpace和VOSviewer软件分析机构、作者和关键词。
共分析了1907篇文章,显示出发表量持续上升的趋势。美国和梅奥诊所被确定为主要贡献者,分别发表了704篇和57篇文章。发文最多的作者Boeve Bradley F发表了30篇文章。观察到国家、机构和作者之间积极开展合作。识别出的高频关键词有“帕金森病”“认知障碍”和“睡眠行为障碍”。新兴研究领域可能集中在“睡眠质量”和“脑淋巴系统”。
本研究首次应用文献计量分析确定了AD与失眠研究的三个关键趋势:美国和梅奥诊所的主导地位、强大的国际合作以及对认知障碍、脑淋巴系统和睡眠干预等关键领域的关注。失眠可能通过多种途径加速AD进展,这表明提高睡眠质量可为早期干预提供新策略。未来研究应优先推进睡眠干预的临床转化并研究脑淋巴系统的机制。